Until now sporadic breast tumors have shown mutations in different genes, with TP53 being the most frequently mutated (44% in tumor and 73–76% in cell lines) [39], [55] particularly in BRCA1 and sporadic basal-like carcinoma [58], [59]. This evidence concerns the gene BRCA1 and neoplasm.